Clinical Trial Update: Sativex Versus Placebo When Added to Existing Treatment for Central Neuropathic Pain in MS [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating Sativex added to existing therapy for central neuropathic pain in people with multiple sclerosis; results of the study were completed…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• Sativex (nabiximol)

Snippet

Sponsor: GW Pharmaceuticals Ltd | Conditions: Multiple Sclerosis | Phase 3 | Status: COMPLETED | Results posted: 2012-07-04